Pamiparib
帕米帕利PARP inhibitor not renewed in the 2026 NRDL adjustment; explicitly granted a 6-month transition period under original payment terms through June 30, 2027.
China Approval (NMPA)
Pending VerificationReimbursement catalog entries for this drug are verified from NHSA official PDFs. Individual NMPA registration certificate numbers (国药准字) and approval dates are queued for incremental verification.
National Reimbursement
Announced · Effective Jan 1, 2027- 2026 Adjustment
- Removed from 2026 NRDL (non-renewed negotiated drug)
- Transition Clause
- Original payment standard continues through Jun 30, 2027
- Prior 2025 Listing
- 2025 NRDL #256 (Class B) — Restricted to patients with gBRCA-mutated recurrent advanced ovarian, fallopian tube, or primary peritoneal cancer after ≥2 prior lines of chemotherapy.
Commercial Insurance List
Not ListedNot listed in the 2025 or 2026 NHSA Commercial Health Insurance Innovative Drug List.
Approved Products, Dosage Forms & Approval Numbers
0 verified NMPA recordsChange Timeline
- (2027-06-30)Transition Clause· Notice published: Nov 14, 2026
6-Month Transition Period Ends
Original negotiated payment standard remains reimbursable through June 30, 2027 per the 2026 NHSA notice.
Chinese original: 未成功续约调出谈判药品给予6个月过渡期,2027年6月底前医保基金可按原支付标准继续支付。
NHSA · Section I(1) Transition ClauseVerified 2026-11-20 - (2027-01-01)Basic NRDL· Catalog published: Nov 14, 2026
2026 NRDL · Removed from Negotiated List
Removed from 2026 NRDL after unsuccessful renewal (was 2025 Negotiated #256); 6-month transition period under original payment standard runs through Jun 30, 2027.
Chinese original: 未成功续约调出2026版目录(原2025版谈判第256项);通知明确给予6个月过渡期,2027年6月30日前可按原支付标准继续支付。
NHSA · Section I(1) Transition ClauseVerified 2026-11-20
Verified Names & Aliases
Every English INN, Chinese generic name, brand name, and R&D code is recorded with its source.
Primary Sources for This Record
- NHSAPublished 2025-12-07国家基本医疗保险、生育保险和工伤保险药品目录(2025年)Retrieved 2026-11-20 · 医保发〔2025〕33号附件
- NHSAPublished 2026-11-14国家医保局 人力资源社会保障部关于印发《国家基本医疗保险、生育保险和工伤保险药品目录》以及《商业健康保险创新药品目录》(2026年)的通知Retrieved 2026-11-20
- NMPA国家药品监督管理局政务服务门户与药品查询Retrieved 2026-11-20
- WHO世界卫生组织国际非专利药名(INN)指南Retrieved 2026-11-20